Assessment of therapeutic effect of CD20-targeted immunoliposome in primary central nervous system lymphoma

Assessment of therapeutic effect of CD20-targeted immunoliposome in primary central nervous system lymphoma

Primary central nervous system lymphoma (PCNSL) is a form of extranodal non-Hodgkin’s B-cell lymphoma limited to the CNS. The treatment of PCNSL is ineffective partly due to the blood-brain barrier (BBB) restriction of delivery of many drugs including anti-CD20 (Rituximab; RTX) which is a standard t...

Full description

Bibliographic Details
Main Authors: Nutthanit Thumrongsiri, Paweena Dana, Rand Bawab, Prattana Tanyapanyachon, Chaichana Treetidnipa, Nattika Saengkrit, Sith Sathornsumetee
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Lymphoma
CNS
CD20
liposome
rituximab
nanoparticle
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332222003687

Internet

http://www.sciencedirect.com/science/article/pii/S0753332222003687

Similar Items